Documents
Application Sponsors
NDA 022420 | STRIDES ARCOLAB LTD | |
Marketing Status
None (Tentative Approval) | 001 |
Application Products
001 | TABLET; ORAL | 200MG | 0 | EFAVIRENZ 200MG SCORED TABLETS | EFAVIRENZ |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | TA | 2010-02-12 | STANDARD |
Submissions Property Types
CDER Filings
STRIDES ARCOLAB LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 22420
[companyName] => STRIDES ARCOLAB LTD
[docInserts] => ["",""]
[products] => [{"drugName":"EFAVIRENZ 200MG SCORED TABLETS","activeIngredients":"EFAVIRENZ","strength":"200MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"EFAVIRENZ 200MG SCORED TABLETS","submission":"EFAVIRENZ","actionType":"200MG","submissionClassification":"TABLET; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)